OxyNov
Nathalie Racette possesses extensive experience in quality assurance, regulatory affairs, and operations management within the pharmaceutical and biotech industries. Currently serving as Responsable AQ et AR at OxyNov since May 2020, Nathalie previously held several key positions including Responsable des affaires réglementaires et assurance qualité at SiliCycle Inc., and Gestionnaire qualité et Affaires réglementaires at Icentia Inc. Notable contributions also came from roles at GSK, where Nathalie managed quality assurance related to quality control and raw materials, overseeing a team of seven. As Leader of continuous improvement at TSO3, significant process enhancements were achieved, and Nathalie has also held various director-level roles at handyem inc. and BD, focusing on operations, regulatory affairs, and quality. Nathalie's academic credentials include a Master's degree in Microbiology and Immunology from Université Laval and a Bachelor's degree in Biochemistry from Université de Montréal.
This person is not in any teams
OxyNov
OxyNov is a young Canadian business focusing on clinical innovation and specialized in designing and commercializing innovative medical devices in the field of oxygen therapy and respiratory care. It was founded in 2009 by Professors Erwan L’Her (head of the Intensive Care Unit and INSERM researcher at the University Hospital of Brest) and FrançoisLellouche (intensivist and researcher at the IUCPQ -Quebec), further to a clinical research project having as an objective the development of a device automating the administration of oxygen therapy and the improvement of the application of this treatment on the daily basis